A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.

Journal of Virology
Shaswath S ChandrasekarAdel M Talaat

Abstract

Infectious bronchitis (IB) caused by infectious bronchitis virus (IBV) is currently a major threat to chicken health, with multiple outbreaks being reported in the United States over the past decade. Modified live virus (MLV) vaccines used in the field can persist and provide the genetic material needed for recombination and emergence of novel IBV serotypes. Inactivated and subunit vaccines overcome some of the limitations of MLV with no risk of virulence reversion and emergence of new virulent serotypes. However, these vaccines are weakly immunogenic and poorly protective. There is an urgent need to develop more effective vaccines that can elicit a robust, long-lasting immune response. In this study, we evaluate a novel adjuvant system developed from Quil-A and chitosan (QAC) for the intranasal delivery of nucleic acid immunogens to improve protective efficacy. The QAC adjuvant system forms nanocarriers (<100 nm) that efficiently encapsulate nucleic acid cargo, exhibit sustained release of payload, and can stably transfect cells. Encapsulation of plasmid DNA vaccine expressing IBV nucleocapsid (N) protein by the QAC adjuvant system (pQAC-N) enhanced immunogenicity, as evidenced by robust induction of adaptive humoral and cellu...Continue Reading

References

Mar 23, 1990·Science·J A WolffP L Felgner
Jan 1, 1973·Archiv für die gesamte Virusforschung·H E GeilhausenP D Lukert
Mar 16, 2000·Developmental and Comparative Immunology·E W CollissonS H Seo
Aug 10, 2000·Revue Scientifique Et Technique·J Ignjatović, S Sapats
Mar 26, 2003·Journal of Internal Medicine·M A Liu
Nov 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Takahiko Matsuda, Constance L Cepko
Jul 7, 2005·International Journal of Pharmaceutics·Olga BorgesHans E Junginger
Dec 23, 2006·Biochemical and Biophysical Research Communications·Oshrat Harush-FrenkelYoram Altschuler
Feb 27, 2007·Journal of Zhejiang University. Science. B·Zahid Iqbal RajputAbdullah G Arijo
Jun 11, 2008·Biomacromolecules·Ioannis A SogiasVitaliy V Khutoryanskiy
Oct 9, 2008·Biochemical and Biophysical Research Communications·Lang TianRun-ming Kang
Jan 5, 2010·The Journal of Veterinary Medical Science·Tai YangYu-Ling Li
Sep 9, 2010·Expert Review of Vaccines·Moses O OyewumiZhengrong Cui
Sep 14, 2010·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Zongxi HanShengwang Liu
Feb 22, 2011·Scandinavian Journal of Immunology·L R NorupH R Juul-Madsen
Jun 19, 2012·Avian Pathology : Journal of the W.V.P.A·Jane K A CookR C Jones
Apr 3, 2014·Avian Diseases·Aline Padilha FragaVagner Ricardo Lunge
Jul 25, 2014·Avian Diseases·Nichole Orr-BurksFrederik W van Ginkel
Oct 23, 2014·Avian Pathology : Journal of the W.V.P.A·J J Sjaak de Wit, Jane K A Cook
Aug 25, 2015·Viral Immunology·Rajesh ChhabraKannan Ganapathy
Mar 18, 2016·Immunity·Nicolas Riteau, Alan Sher
Jun 7, 2017·Chemical Society Reviews·Shahed BehzadiMorteza Mahmoudi
Nov 22, 2017·Pharmaceutics·Munawar A MohammedEllen K Wasan
Jan 9, 2019·Frontiers in Immunology·Nataschja I HoGosse J Adema
Jul 14, 2019·Vaccine·Brock A Kingstad-BakkeAdel M Talaat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.